Shares of Florida-based cannabis multi-state operator (MSO) Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF) saw a double-digit jump thanks to the start of smokables in the state.

The company confirmed the start of sales for smokable items on Thursday (March 21), with the first sale taking place at its Tallahassee dispensary.


On Monday (March 18), Florida Governor Ron DeSantis officially removed the ban on smokable cannabis products, according to a report from the Tallahassee Democrat.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The state faced a lawsuit and the eventual vote supported lifting the ban and allowing the sale of these products.

“Offering these whole flower products to our patients in their purest, most effective form is something we — and patients — have been looking forward to since we opened the doors of the state’s first dispensary,” Kim Rivers, CEO of Trulieve, said in a press release.

Trulieve had an 11.35-percent bump to its share price and finished the trading day at C$18.35 per share.

The company holds a market capitalization of C$136.2 million.

Trulieve, which has 26 dispensaries in the state, informed shareholders that Florida now has over 190,000 registered patients capable of buying medical-marijuana products.

During its fiscal Q4 2018 results conference call, Joseph Lusardi, CEO of fellow MSO Curaleaf (CSE:CURA,OTCQX:CURLF), said the company now expects the Florida market to double thanks to the change in the state.

The executive added that he also now expects to see some form of policy on edibles this year. Curaleaf currently operates 22 stores in Florida.

Despite its status as a medical-only market, Florida has quickly ascended as one of the top states in the minds of analysts.

Both Neal Gilmer, an analyst with Haywood Securities, and Matt Bottomley, director of equity research at Canaccord Genuity Group (TSX:CF), have expressed bullish sentiment for the state.

The market has attracted the attention of fellow MSO Cresco Labs (CSE:CL,OTCQX:CRLBF).

Alongside the lift on the smokable products on Monday, the firm announced it will pay US$120 million for the acquisition of VidaCann.

This venture holds in its portfolio seven active dispensaries. Additionally, three new stores have been completed and are only missing operational approval, with four extra stores set to be under construction by June.

According to research from the Arcview Market Research and BDS Analytics, the Florida cannabis market is estimated to be worth US$1.7 billion by 2022.

During the Canaccord Growth Investor Day event in Vancouver, Rivers told the audience she is not expecting to see a vote on adult-use marijuana until the 2024 elections.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Green Growth Brands is a client of the Investing News Network. This article is not paid-for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less

Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.

Keep reading... Show less